James Bauersmith

James Bauersmith

Direttore/Membro del Consiglio presso LANNETT COMPANY, INC.
Health Technology
Consumer Services
Health Services

Profilo

James Bauersmith is currently the Director at Lannett Co., Inc. and the Vice President & Translational Sciences at UPMC Enterprises.
Previously, he worked as the Director at Akorn, Inc., the SVP & Head of Global Drug Portfolio Strategy at Fresenius SE & Co. KGaA, the Chief Strategy Officer & General Counsel at ByHeart, Inc., and the SVP Head of Corporate Development & Procurement at Amneal Pharmaceuticals, Inc. Mr. Bauersmith received his undergraduate degree from the University of Notre Dame in 1998 and his graduate degrees from Drexel University in 2005 and The Pennsylvania State University in 2001.

Posizioni attive di James Bauersmith

SocietàPosizioneInizio
LANNETT COMPANY, INC. Direttore/Membro del Consiglio -
Corporate Officer/Principal 01/08/2021

Precedenti posizioni note di James Bauersmith

SocietàPosizioneFine
Consigliere Generale 01/10/2021
AMNEAL PHARMACEUTICALS, INC. Corporate Officer/Principal 30/06/2019
FRESENIUS SE & CO. KGAA Corporate Officer/Principal 31/05/2018
AKORN, INC. Direttore/Membro del Consiglio -
Vedi nel dettaglio l'esperienza di James Bauersmith

Formazione di James Bauersmith

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

90

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private9

Health Technology

Health Technology

Health Services

Consumer Services

Consumer Services

Consumer Services

Finance

Consumer Non-Durables

Health Technology

  1. Mercati
  2. Insiders
  3. James Bauersmith